Condition
Vaso-Occlusive Pain Episode in Sickle Cell Disease clinical trials and research
Research outlook What's coming for Sickle cell disease: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 4 Vaso-Occlusive Pain Episode in Sickle Cell Disease clinical trials that are recruiting, at sites in 3 countries (most in United States (3), France (1), Guadeloupe (1)). By phase: Phase 2 (1), Phase 3 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Vaso-Occlusive Pain Episode in Sickle Cell Disease clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Low-dose ketamine for sickle cell vaso-occlusive pain in children and young adults | Phase 2 | Torrance, California | Recruiting | Jan 27, 2026 |
| Lidocaine to Help Spare Opioids During Vaso-occlusive Crises in Sickle Cell Disease | Phase 3 | Bordeaux and 11 other locations | Recruiting | Dec 10, 2025 |
| Depo-Provera (depot medroxyprogesterone acetate) for pain and biomarker changes in women with sickle cell disease | Phase 4 | Atlanta, Georgia and 1 other locations | Recruiting | Oct 30, 2024 |
| Using virtual reality to help manage pain in sickle cell disease patients | — | Baltimore, Maryland | Recruiting | Dec 28, 2023 |
All recruiting trials (4)
-
Low-dose ketamine for sickle cell vaso-occlusive pain in children and young adults
This trial will test whether adding a low (sub-dissociative) dose ketamine infusion to usual IV opioid pain medicine helps children and young adults (ages 5–20) with sickle cell disease have better pain relief and remain safe during a vaso-occlusive episode.
-
Lidocaine to Help Spare Opioids During Vaso-occlusive Crises in Sickle Cell Disease
This study tests whether adding lidocaine to standard pain care during a vaso-occlusive crisis can reduce the total opioid use in adults with sickle cell disease.
-
Depo-Provera (depot medroxyprogesterone acetate) for pain and biomarker changes in women with sickle cell disease
This study will test whether an injectable birth control (Depo-Provera) can reduce pain in adult women with sickle cell disease.
-
Using virtual reality to help manage pain in sickle cell disease patients
This study is testing if using virtual reality can help adults with sickle cell disease feel less pain during painful episodes.
Related topics
Quick answers
How many Vaso-Occlusive Pain Episode in Sickle Cell Disease clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), France (1 trial), Guadeloupe (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 3: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.